EP3374359
Díhýdróimídasópýrasínónafleiður sem eru nytsamlegar við meðhöndlun á krabbameini
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
8.11.2016EP published:
8.1.2020EP application number:
16791420.9
EP translation filed:
23.3.2020Grant published:
15.4.2020EPO information:
European Patent Register
Max expiry date:
7.11.2036Expiry date:
7.11.2024
Title:
DIHYDROIMIDAZOPYRAZINONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER
Timeline
Today
8.11.2016EP application
8.1.2020EP Publication
23.3.2020Translation submitted
15.4.2020Registration published
7.11.2024Expires
Owner
Name:
AstraZeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
WARD, Richard, AndrewAddress:
Milton Road Cambridge CB4 0WG, GB
Name:
JONES, Clifford, DavidAddress:
Macclesfield Cheshire SK10 4TG, GB
Name:
SWALLOW, StevenAddress:
Macclesfield Cheshire SK10 2NA, GB
Name:
GRAHAM, Mark, AndrewAddress:
Macclesfield Cheshire SK10 2NA, GB
Name:
DOBSON, Andrew, HornbyAddress:
Macclesfield Cheshire SK10 2NA, GB
Name:
MCCABE, James, FrancisAddress:
Macclesfield Cheshire SK10 2NA, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562252726 PDate:
9.11.2015Country:
US
Number:
201662401351 PDate:
29.9.2016Country:
US
Classification
Categories:
C07D 487/04, A61K 31/4985, A61P 35/00, C07D 403/04
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 27.10.2020
Expires: 7.11.2021
Payer: Árnason Faktor ehf.
Number: 6
Paid: 7.10.2021
Expires: 7.11.2022
Payer: Árnason Faktor ehf.
Number: 7
Paid: 27.10.2022
Expires: 7.11.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 15.11.2023
Expires: 7.11.2024
Payer: Árnason Faktor ehf.